17 Einträge gefunden

1. Therapiealgorithmen für das Mammakarzinom

   1. Blohmer, Jens-Uwe
   2. Schneeweiss, Andreas
   3. Bauerfeind, I.
   4. Fehm, T
   5. Muller , Volkmar
   6. Thomssen, Christoph
   7. Witzel, Isabell

   2021 - Forschungsinformationssystem des UKE
2. Optimizing expectations about cancer treatment: Results of the randomized controlled PSY-BREAST trial

   1. Shedden-Mora, Meike C.
   2. Pan, Yiqi
   3. Heisig, Sarah
   4. von Blanckenburg, Pia
   5. Rief, Winfried
   6. Witzel, Isabell
   7. Albert, Ute-Susann

   2020 - Forschungsinformationssystem des UKE - frei zugänglich
3. Therapieoptionen beim hormonrezeptorpositiven, HER-2-negativen metastasierten Mammakarzinom

   1. Wöckel, Achim
   2. Bauerfeind, Ingo
   3. Fehm, Tanja
   4. Janni, Wolfgang
   5. Muller , Volkmar
   6. Thill, Marc
   7. Thomssen, Christoph

   2020 - Forschungsinformationssystem des UKE
4. Hereditäres Mamma- und Ovarialkarzinom. Prophylaktische Operation: Für wen und wann?

   1. Witzel, Isabell

   2020 - Forschungsinformationssystem des UKE
5. Zerebrale Metastasierung beim Mammakarzinom

   1. Muller , Volkmar
   2. Laakmann, Elena
   3. Grottke, Astrid
   4. Riecke, Kerstin
   5. Witzel, Isabell

   2018 - Forschungsinformationssystem des UKE
6. HER2-positive Mammakarzinome

   1. Witzel, Isabell
   2. Muller , Volkmar

   2017 - Forschungsinformationssystem des UKE
7. Prognostic and predictive relevance of CA-125 at primary surgery of ovarian cancer.

   1. Schütze, Dina
   2. Wölber, Linn
   3. Jung, Sabine
   4. Zu Eulenburg, Christine Gräfin
   5. Choschzick, Matthias
   6. Witzel, Isabell
   7. Schwarz, Jörg

   2011 - Forschungsinformationssystem des UKE
8. Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial.

   1. Witzel, Isabell
   2. Loibl, Sibylle
   3. von Minckwitz, Gunter
   4. Mundhenke, Christoph
   5. Huober, Jens
   6. Hanusch, Claus
   7. Henschen, Stephan

   2010 - Forschungsinformationssystem des UKE
9. Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.

   1. Henningsen, Maike
   2. Köhler, N
   3. Kersten, Jan Felix
   4. Milde-Langosch, Karin
   5. Beck, K
   6. Höller, S
   7. Müller, Volkmar

   2010 - Forschungsinformationssystem des UKE - frei zugänglich
10. Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer.

    1. Henningsen, Maike
    2. Wirtz, R M
    3. Kalogeras, K T
    4. Milde-Langosch, Karin
    5. Schmidt, M
    6. Witzel, Isabell
    7. Eleftheraki, A G

    2010 - Forschungsinformationssystem des UKE
11. Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome.

    1. Witzel, Isabell
    2. Milde-Langosch, Karin
    3. Wirtz, Ralph M
    4. Roth, Claudia
    5. Henningsen, Maike
    6. Mahner, Sven
    7. Zu Eulenburg, Christine Gräfin

    2010 - Forschungsinformationssystem des UKE
12. Single-center management of 136 patients with cancer of unknown primary site (CUP syndrome) over a period of 10 years.

    1. Thoem, Ina
    2. Rogers, Claudia
    3. Andritzky, Birte
    4. Witzel, Isabell
    5. Schuch, Gunter
    6. Hossfeld, Dieter Kurt
    7. Bokemeyer, Carsten

    2009 - Forschungsinformationssystem des UKE
13. Trastuzumab in pregnancy associated with poor fetal outcome.

    1. Witzel, Isabell
    2. Müller, Volkmar
    3. Harps, E
    4. Jänicke, Fritz
    5. De Wit, Maike

    2008 - Forschungsinformationssystem des UKE
14. Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.

    1. Henningsen, Maike
    2. Müller, Volkmar
    3. Wirtz, R M
    4. Schröder, Christine
    5. Krenkel, S
    6. Witzel, Isabell
    7. Lisboa, B W

    2008 - Forschungsinformationssystem des UKE
15. Clinical utility of determination of HER-2/neu and EGFR fragments in serum of patients with metastatic breast cancer.

    1. Witzel, Isabell
    2. Thomssen, C
    3. Krenkel, S
    4. Wilczak, Waldemar
    5. Bubenheim, M
    6. Pantel, K
    7. Neumann, R

    2006 - Forschungsinformationssystem des UKE
16. Prognostic and predictive impact of soluble epidermal growth factor receptor (sEGFR) protein in the serum of patients treated with chemotherapy for metastatic breast cancer.

    1. Müller, Volkmar
    2. Witzel, Isabell
    3. Pantel, Klaus
    4. Krenkel, Sylke
    5. Lück, Hans Joachim
    6. Neumann, Rainer
    7. Keller, Thomas

    2006 - Forschungsinformationssystem des UKE
17. Prognostic and predictive impact of the HER-2/ neu extracellular domain (ECD) in the serum of patients treated with chemotherapy for metastatic breast cancer.

    1. Müller, Volkmar
    2. Witzel, Isabell
    3. Lück, Hans Joachim
    4. Köhler, Günter
    5. von Minckwitz, Gunther
    6. Möbus, Volker
    7. Sattler, Daniel

    2004 - Forschungsinformationssystem des UKE